{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:34:16Z","timestamp":1788572056647,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>As noted in other flaviviruses, the envelope (E) protein of Japanese encephalitis virus (JEV) interacts with a cellular receptor and mediates membrane fusion to allow viral entry into target cells, thus eliciting neutralizing antibody response. The formation of the flavivirus prM\/E complex is followed by the cleavage of precursor membrane (prM) and membrane (M) protein by a cellular signalase. To test the effect of prM in JEV biology, we constucted JEV-MuLV pseudotyped viruses that express the prM\/E protein or E only. The infectivity and titers of JEV pseudotyped viruses were examined in several cell lines. We also analyzed the neutralizing capacities with anti-JEV sera from JEV-immunized mice. Even though prM is crucial for multiple stages of JEV biology, the JEV-pseudotyped viruses produced with prM\/E or with E only showed similar infectivity and titers in several cell lines and similar neutralizing sensitivity. These results showed that JEV-MuLV pseudotyped viruses did not require prM for production of infectious pseudotyped viruses.<\/jats:p>","DOI":"10.1186\/1743-422x-6-115","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T18:13:53Z","timestamp":1248977633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The prM-independent packaging of pseudotyped Japanese encephalitis virus"],"prefix":"10.1186","volume":"6","author":[{"given":"Hee Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Il","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin-Hyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonkyung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hwan","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ran","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,30]]},"reference":[{"key":"629_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","volume":"72","author":"G Kuno","year":"1998","unstructured":"Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB: Phylogeny of the genus Flavivirus. J Virol 1998, 72: 73-83.","journal-title":"J Virol"},{"key":"629_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/0264-410X(94)90329-8","volume":"12","author":"K Venugopal","year":"1994","unstructured":"Venugopal K, Gould EA: Towards a new generation of flavivirus vaccines. Vaccine 1994, 12: 966-975. 10.1016\/0264-410X(94)90329-8","journal-title":"Vaccine"},{"key":"629_CR3","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/jvi.64.6.2788-2795.1990","volume":"64","author":"A Yasuda","year":"1990","unstructured":"Yasuda A, Kimura-Kuroda J, Ogimoto M, Miyamoto M, Sata T, Sato T, Takamura C, Kurata T, Kojima A, Yasui K: Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus. J Virol 1990, 64: 2788-2795.","journal-title":"J Virol"},{"key":"629_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/13550280390218454","volume":"9","author":"R Kaur","year":"2003","unstructured":"Kaur R, Vrati S: Development of a recombinant vaccine against Japanese encephalitis. J Neurovirol 2003, 9: 421-431. 10.1080\/713831600","journal-title":"J Neurovirol"},{"key":"629_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0168-1702(97)00098-1","volume":"51","author":"SC Wu","year":"1997","unstructured":"Wu SC, Lian WC, Hsu LC, Liau MY: Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res 1997, 51: 173-181. 10.1016\/S0168-1702(97)00098-1","journal-title":"Virus Res"},{"key":"629_CR6","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/JVI.78.5.2367-2381.2004","volume":"78","author":"P Keelapang","year":"2004","unstructured":"Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, Jairungsri A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N: Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses. J Virol 2004, 78: 2367-2381. 10.1128\/JVI.78.5.2367-2381.2004","journal-title":"J Virol"},{"key":"629_CR7","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","volume":"75","author":"E Konishi","year":"2001","unstructured":"Konishi E, Fujii A, Mason PW: Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol 2001, 75: 2204-2212. 10.1128\/JVI.75.5.2204-2212.2001","journal-title":"J Virol"},{"key":"629_CR8","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1128\/JVI.73.12.10137-10145.1999","volume":"73","author":"HW Chen","year":"1999","unstructured":"Chen HW, Pan CH, Liau MY, Jou R, Tsai CJ, Wu HJ, Lin YL, Tao MH: Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 1999, 73: 10137-10145.","journal-title":"J Virol"},{"key":"629_CR9","first-page":"91","volume":"267","author":"I Kurane","year":"2002","unstructured":"Kurane I: Immune responses to Japanese encephalitis virus. Curr Top Microbiol Immunol 2002, 267: 91-103.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"Pt 8","key":"629_CR10","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","volume":"70","author":"PW Mason","year":"1989","unstructured":"Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, Burke DS, Fournier MJ, Mason TL: Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 1989,70(Pt 8):2037-2049. 10.1099\/0022-1317-70-8-2037","journal-title":"J Gen Virol"},{"key":"629_CR11","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1128\/JVI.77.16.8745-8755.2003","volume":"77","author":"A Kojima","year":"2003","unstructured":"Kojima A, Yasuda A, Asanuma H, Ishikawa T, Takamizawa A, Yasui K, Kurata T: Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine. J Virol 2003, 77: 8745-8755. 10.1128\/JVI.77.16.8745-8755.2003","journal-title":"J Virol"},{"key":"629_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.vaccine.2003.02.001","volume":"22","author":"HH Wu","year":"2004","unstructured":"Wu HH, Chen CT, Lin YL, Lee ST: Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming \u2013 protein boosting immunization strategies. Vaccine 2004, 22: 793-800.","journal-title":"Vaccine"},{"key":"629_CR13","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1128\/JVI.77.7.4248-4260.2003","volume":"77","author":"Z Zhao","year":"2003","unstructured":"Zhao Z, Wakita T, Yasui K: Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB\/c mice. J Virol 2003, 77: 4248-4260. 10.1128\/JVI.77.7.4248-4260.2003","journal-title":"J Virol"},{"key":"629_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","volume":"188","author":"E Konishi","year":"1992","unstructured":"Konishi E, Pincus S, Paoletti E, Shope RE, Burrage T, Mason PW: Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection. Virology 1992, 188: 714-720. 10.1016\/0042-6822(92)90526-U","journal-title":"Virology"},{"key":"629_CR15","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1128\/JVI.00789-08","volume":"82","author":"JM Kim","year":"2008","unstructured":"Kim JM, Yun SI, Song BH, Hahn YS, Lee CH, Oh HW, Lee YM: A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice. J Virol 2008, 82: 7846-7862. 10.1128\/JVI.00789-08","journal-title":"J Virol"},{"key":"629_CR16","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.1073\/pnas.90.17.8033","volume":"90","author":"JC Burns","year":"1993","unstructured":"Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993, 90: 8033-8037. 10.1073\/pnas.90.17.8033","journal-title":"Proc Natl Acad Sci USA"},{"key":"629_CR17","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1089\/08892220152741414","volume":"17","author":"YB Kim","year":"2001","unstructured":"Kim YB, Lee MK, Han DP, Cho MW: Development of a safe and rapid neutralization assay using murine leukemia virus pseudotyped with HIV type 1 envelope glycoprotein lacking the cytoplasmic domain. AIDS Res Hum Retroviruses 2001, 17: 1715-1724. 10.1089\/08892220152741414","journal-title":"AIDS Res Hum Retroviruses"},{"key":"629_CR18","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1073\/pnas.94.16.8640","volume":"94","author":"BS Schnierle","year":"1997","unstructured":"Schnierle BS, Stitz J, Bosch V, Nocken F, Merget-Millitzer H, Engelstadter M, Kurth R, Groner B, Cichutek K: Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci USA 1997, 94: 8640-8645. 10.1073\/pnas.94.16.8640","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-6-115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:30:31Z","timestamp":1630459831000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-6-115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,30]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-6-115","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,30]]},"assertion":[{"value":"20 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"115"}}